Indeed, we report here that gene expression microarray analysis comparing chemotherapy-sensitive and chemoresistant ovarian cancer cells reveals downregulation of specific RGS transcripts during acquired chemoresistance. The gene discussed is PITX2; the disease is ovarian carcinoma.